EP2680908A1 - Bouchon pour seringue et procédé de fabrication - Google Patents

Bouchon pour seringue et procédé de fabrication

Info

Publication number
EP2680908A1
EP2680908A1 EP12706468.1A EP12706468A EP2680908A1 EP 2680908 A1 EP2680908 A1 EP 2680908A1 EP 12706468 A EP12706468 A EP 12706468A EP 2680908 A1 EP2680908 A1 EP 2680908A1
Authority
EP
European Patent Office
Prior art keywords
cap
closure
retaining ring
syringe
securing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP12706468.1A
Other languages
German (de)
English (en)
Inventor
Tilman Roedle
Paul Nelles
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vetter Pharma Fertigung GmbH and Co KG
Original Assignee
Vetter Pharma Fertigung GmbH and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE201110013791 external-priority patent/DE102011013791A1/de
Priority claimed from DE201110111552 external-priority patent/DE102011111552A1/de
Application filed by Vetter Pharma Fertigung GmbH and Co KG filed Critical Vetter Pharma Fertigung GmbH and Co KG
Publication of EP2680908A1 publication Critical patent/EP2680908A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/3129—Syringe barrels
    • A61M5/3134—Syringe barrels characterised by constructional features of the distal end, i.e. end closest to the tip of the needle cannula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/1412—Containers with closing means, e.g. caps
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29D—PRODUCING PARTICULAR ARTICLES FROM PLASTICS OR FROM SUBSTANCES IN A PLASTIC STATE
    • B29D99/00—Subject matter not provided for in other groups of this subclass
    • B29D99/0096—Producing closure members for containers, e.g. closure caps or stoppers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M2005/3103—Leak prevention means for distal end of syringes, i.e. syringe end for mounting a needle
    • A61M2005/3104—Caps for syringes without needle
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M2005/3117—Means preventing contamination of the medicament compartment of a syringe
    • A61M2005/3118—Means preventing contamination of the medicament compartment of a syringe via the distal end of a syringe, i.e. syringe end for mounting a needle cannula
    • A61M2005/312—Means preventing contamination of the medicament compartment of a syringe via the distal end of a syringe, i.e. syringe end for mounting a needle cannula comprising sealing means, e.g. severable caps, to be removed prior to injection by, e.g. tearing or twisting
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2207/00—Methods of manufacture, assembly or production
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/32—Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles
    • A61M5/34—Constructions for connecting the needle, e.g. to syringe nozzle or needle hub
    • A61M5/347—Constructions for connecting the needle, e.g. to syringe nozzle or needle hub rotatable, e.g. bayonet or screw

Definitions

  • the invention relates to a syringe according to the preamble of claim 1, a closure for a syringe according to the preamble of claim 4 and a method for producing a closure according to the preamble of claim 11.
  • syringes preferably prefilled with a medical and / or pharmaceutical preparation, during its storage or before its use, it has a closure.
  • This comprises a sealing cap which seals the needle hub and a securing cap which engages around the closure cap and is fastened to the needle hub via a retaining ring.
  • the syringe which is preferably suitable and intended for medical purposes, is thus tightly closed during its storage by the closure cap in the region of the needle hub so that a preparation provided in the syringe does not escape and is not contaminated by externally penetrating substances and / or germs can be.
  • Known closures are composed of separate parts.
  • the safety cap and the cap are provided as separate parts. They are manufactured in separate process steps and assembled for assembly on the syringe. Since these are small parts, they can easily be lost. The separate production steps and the separate storage of the individual parts bring a significant logistical effort. Due to the additional necessary assembly step to assemble the separate parts of the closure, the production of the closure and thus also the syringe becomes more expensive.
  • the object of the invention is therefore to provide a syringe, a closure and a method for producing the closure, which do not have the disadvantages mentioned.
  • a closure with the features of claim 1 is provided.
  • This is characterized in that at least the fuse cap and the cap are integrally formed. They are therefore jointly handled and storable, so that not one of the two parts can be lost, and these must not be assembled before or during a final assembly of the syringe. As a result, the logistical effort is significantly reduced, and it eliminates an additional production step.
  • a closure for a syringe with the features of claim 4 is provided.
  • This has a closure cap for sealing the syringe, a locking cap which surrounds the closure cap, a retaining ring for fastening the closure to the syringe and a securing ring which surrounds the retaining ring and to which the securing cap is detachably attached.
  • the closure is characterized in that at least the cap and the safety cap are integrally formed. This results in the already mentioned in connection with the syringe advantages.
  • a closure which is characterized in that the safety cap, the retaining ring and / or the retaining ring comprises a comparatively hard material / include.
  • the fuse cap support the cap and in particular absorb forces that would otherwise possibly lead to an unintentional removal of the cap.
  • the retaining ring and the retaining ring have the necessary stability in order to fulfill their retaining function if they comprise a hard material. More preferably, the hard material is a thermoplastic polymer, most preferably polypropylene. It is also preferred that the safety cap, the retaining ring and / or the retaining ring consist of the hard material, preferably the thermoplastic polymer, most preferably polypropylene.
  • closure cap comprises a soft or elastic material.
  • the soft or elastic material is preferably a thermoplastic elastomer (TPE).
  • TPE thermoplastic elastomer
  • the closure cap consists of the soft material, preferably of TPE.
  • a closure in which the safety cap and the cap in a two-component ten injection molding process are made as a one-piece element.
  • the securing cap from a comparatively hard and the closure cap from a comparatively soft or elastic material, wherein both are manufactured in one piece in one and the same process.
  • a safety cap is injected from a first, preferably hard material.
  • a closure cap is injected from a second, preferably soft material. Either the cap is sprayed onto the safety cap, or the safety cap is sprayed onto the cap. So ultimately it does not matter in which order the parts are molded by injection molding. It is essential that the safety cap and the cap are made in one piece from different materials, wherein the one element is molded to the other element in the injection molding process.
  • the circlip is molded in the same multi-component injection molding process as the fuse cap and the cap.
  • the securing ring can be molded onto the securing cap.
  • the retaining ring is molded in the same multi-component injection molding process. This allows otherwise separate process steps to be integrated into a multi-component injection molding process.
  • the safety cap, the retaining ring and preferably also the retaining ring are formed in one step from the same material.
  • the entire closure is produced in the multi-component injection molding process as a one-piece element.
  • a method is preferred in which the securing cap and the closure cap are locked together during injection molding.
  • the safety cap is removed, the cap is taken from the safety cap when it is locked with it.
  • the needle hub is then accessible in one step, and the safety cap and cap need not be removed separately.
  • Figure 1 is a sectional view of an embodiment of a syringe with not completely attached closure, and a detailed view of the sectional view of a syringe in the closed state.
  • 1 shows a representation of an embodiment of a syringe 1 in longitudinal section in a state in which a closure 3 is not yet fully seated on the syringe 1.
  • the syringe 1 has a syringe barrel 5, which preferably receives a medical and / or pharmaceutical preparation.
  • the syringe 1 is preferably used for medical purposes.
  • the syringe cylinder 5 of the preferably prefilled syringe 1 is preferably closed by a stopper, not shown, in the region of a proximal end P. The stopper can be moved inside the syringe barrel 5 in order to expel the preparation via a needle hub 7 provided at a distal end D.
  • needle hub serves to couple the syringe 1 with a dispensing means.
  • this may be a needle or cannula.
  • other delivery means as are conventional in the medical field, to the needle hub 7, for example a tube of an injection system or other medical device.
  • the closure 3 comprises a closure cap 9, which is designed so that the needle attachment piece 7 can be closed in a sealing manner. It further comprises a safety cap 11, which surrounds the closure cap 9.
  • the safety cap 11 is attached via a retaining ring 13 to the Nadelansatz Sharing.
  • a locking ring 15 is provided, on which the fuse cap 11 is detachably attached.
  • At least one of the securing cap 11 and the securing ring 15 is particularly preferred connecting tear-off provided, so that these elements are virtually interconnected via a predetermined breaking point.
  • a plurality of tear-off webs-in the circumferential direction preferably distributed at an equal angular distance from each other-are provided, which connect the securing ring 15 and the securing cap 11 to one another.
  • projections can be provided on the securing ring 15 and / or the securing cap 11, which projections extend in the direction of the other element.
  • This support forces can be initiated when a shift of the fuse cap 11 and the locking ring 15 - in the longitudinal direction of the syringe 1, ie in the axial direction - to each other. This avoids that the tear-off webs accidentally break when axial compressive forces are introduced into the safety cap 11. On the other hand, they should tear as intended if axial tensile forces are introduced into the safety cap 11.
  • the syringe 1 in the region of the needle hub 7 a fastening means preferably a groove, a bead or - as in the embodiment shown here - an undercut 17, by means of which the retaining ring 13 can be attached to the Nadelansatz Sharing 7.
  • the retaining ring 13 can be attached to the Nadelansatz Sharing 7.
  • it is pushed from above onto the needle hub 7 and engages below the undercut 17 a. It is then preferably no longer possible to remove it non-destructively.
  • the circlip 15 has a preferably annular, radially inwardly projecting projection 19, with which he in up- set state behind an undercut 21 on the retaining ring 13 engages. In the exemplary embodiment shown in FIG. 1, it is therefore also preferably pushed onto the retaining ring 13 from above and finally engages with the projection 19 behind the undercut 21. It is then preferably no longer possible to separate the retaining ring 15 nondestructively from the retaining ring 13. Therefore, the safety cap 11 ruptures in the region of the at least one tear-off web from the securing ring 15 when axial tensile forces are introduced into it.
  • the needle hub 7 is preferably formed as a cone, most preferably as a Luer cone.
  • the retaining ring 13 preferably comprises a in the direction of the Nadelansatz Sharings 7, ie in the axial direction extending wall portion 23 which is formed in the illustrated embodiment as a thread, preferably as a Luer thread.
  • a thread preferably as a Luer thread.
  • closure cap 9 and the safety cap 11 are integrally formed. In this way, both elements can be handled together and stored together.
  • the closure cap 9 preferably comprises a soft material; it preferably consists of this.
  • the material is preferably softer or more elastic than the material of the needle hub 7.
  • the cap 9 is preferably stretched elastically so that it rests sealingly against the needle hub 7. It preferably has a central projection 25, which in the mounted state in sealing engagement with an orifice 27 of the Nadelansatz Sharings 7 comes to further increase the sealing effect.
  • the soft or elastic material is preferably a thermoplastic elastomer (TPE).
  • TPE thermoplastic elastomer
  • TPE-V crosslinked thermoplastic elastomer
  • the closure 3 and the entire syringe 1 are preferably designed such that the medical and / or pharmaceutical preparation comes into contact exclusively with materials which are suitable for primary contact.
  • the needle hub 7 preferably comprises glass or preferably consists of this.
  • a preferably hard plastic is used as material for the needle hub 7. This is preferably formed integrally with the syringe barrel 5 and particularly preferably comprises the same material as this.
  • the safety cap 11 preferably comprises a comparatively hard material or preferably consists of this material.
  • the material is preferably harder than the material of the closure cap 9 so that the safety cap 11 can support it and absorb forces introduced into it. It also serves to protect the cap 9 from external forces acting on it so that it is not accidentally removed.
  • the hard material is preferably a thermoplastic polymer, more preferably polypropylene.
  • the locking ring 15 and preferably also the retaining ring 13 comprise a comparatively hard material or consist of this. Particularly preferably, they comprise or consist of the same material as the safety cap 11.
  • the securing ring 15 and the retaining ring 13 can fulfill their securing or holding function particularly well if they consist of a comparatively hard material.
  • the material of the retaining ring 13 is at least slightly more elastic than the material comprising the Nadelansatz- piece 7.
  • the retaining ring 13 is at least slightly more elastic than the material comprising the Nadelansatz- piece 7.
  • the inner diameter of the retaining ring 13 is suitably matched to the outer diameter of the syringe 1 in the region in Figure 1 below the undercut 17. It is then no longer possible to remove it non-destructively from the needle hub 7.
  • the securing ring 15 is preferably formed by the choice of its wall thickness so that it can be easily widened when pushed onto the retaining ring 13, wherein finally the projection 19 elastically - seen in the direction of slipping - springs behind the undercut 21.
  • the circlip 15 is then preferably under bias to the retaining ring 13, so that it is no longer possible to deduct it non-destructively again.
  • the retaining ring 15 and the retaining ring 13 may be integrally formed. They are then not assembled as described, but form a single, one-piece element which is placed on the needle attachment piece 7.
  • they can be manufactured as an integral element in an injection molding process. If they include the same material, a single injection molding step is sufficient. However, they can also comprise different materials, whereby they can then preferably be produced in a two-component injection molding process.
  • the safety cap 11 and the closure cap 9 are also preferably produced in a two-component injection molding process as a one-piece element.
  • the safety cap 11 and the snap ring 15 are made of the same material as a one-piece element in a single injection molding step.
  • the at least one tear bar, which connects the two parts is also formed.
  • the closure cap 9 is then preferably produced in a further injection molding step.
  • the retaining ring 13 can be manufactured separately. But it is also possible to manufacture it preferably in the same injection molding step of the same material together with the safety cap 11 and the retaining ring 15.
  • the entire closure 3 can be produced as a one-piece element in a multi-component injection molding process. He then just has to be pushed onto the needle hub piece 7 until the retaining ring 13 - seen in the direction of slipping - behind the undercut 17 snaps to close the syringe 1.
  • Figure 2 shows a detailed view of the embodiment of the syringe 1 according to Figure 1 in longitudinal section in the closed state.
  • the same and functionally identical elements are provided with the same reference numerals, so that reference is made to the preceding description.
  • Figure 2 is darg Hormine that the retaining ring 15 in the present embodiment with the jump 19, the undercut 21 engages latching behind. Since the securing cap 11 is connected to the circlip 15 via the at least one breaker bar, it is indirectly fastened to the needle hub 7 via the retaining ring 13 because the circlip 15 is fastened to the retaining ring 13, which in turn is fastened to the needle hub 7 , in which he almost engages behind the undercut 17 latching.
  • the needle hub 7 and the cap 9 are shown as overlapping, because in Figure 2, the deformation of the soft or elastic material of the cap 9 is not considered. From this representation, however, it is particularly clear that in fact the closure cap 9 is elastically deformed when placed on the needle hub 7, so that it rests sealingly against it. In particular, the projection 25 ensures a tight covering of the mouth 27.
  • the method for producing a closure is explained in more detail below: First, either the safety cap 1 1 is injection molded from a first, preferably hard material, or the cap 9 is injection molded from a second, preferably soft material. Subsequently, either the cap 9 is sprayed onto the fuse cap 11, or the fuse cap 11 is sprayed onto the cap 9. In any case, both elements are preferably molded integrally into one another in a two-component injection molding process.
  • the securing ring 15 is preferably also formed in the same multi-component injection-molding method. In particular, it is possible to mold it in the same injection molding step together with the safety cap 1 1, if it comprises the same material as this. At the same time, the at least one tear-off bar is also formed, which connects the two elements to one another.
  • the closure cap 9 is then formed in accordance with the unit of fuse cap 11 and retaining ring 15, or this unit is formed on the cap 9.
  • the retaining ring 13 is formed in the same multi-component injection molding process as the safety cap 11 and the closure cap 9.
  • the safety cap 11, the retaining ring 15 and the retaining ring 13 in an injection molding step of the same material. Subsequently, the closure cap 9 can then be molded into this unit, or the unit can be molded onto the closure cap 9. This creates the closure 3 as a completely one-piece Element, which only has to be placed on the needle hub 7 to close the syringe 1.
  • the retaining ring 15 and the retaining ring 13 in the same multi-component injection molding method as the safety cap 11 and the closure cap 9, but at least one additional injection molding step for forming the securing ring 15 and / or Provide retaining rings 13.
  • the securing ring 15 and / or the retaining ring 13 of the fuse cap 11 and / or comprise different materials it is possible to form the retaining ring 15 and the retaining ring 13 in the same multi-component injection molding method as the safety cap 11 and the closure cap 9, but at least one additional injection molding step for forming the securing ring 15 and / or Provide retaining rings 13.
  • the closure cap is preferably injection-molded from a material which comprises, preferably consists of, thermoplastic elastomer (TPE).
  • TPE thermoplastic elastomer
  • the safety cap 11 and the closure cap 9 are locked together during injection molding.
  • at least one recess 29 is preferably provided on the closure cap 9, into which at least one projection 31 of the safety cap 11 engages. It is also possible to provide a recess on the securing cap 11 into which a corresponding projection of the Closure cap 9 engages. Finally, it is possible to provide on both elements at least one recess and at least one projection, which interlock latching.
  • closure cap 9 and the securing cap 11 then comprise the corresponding latching means, namely projections and / or recesses.
  • the at least one recess 29 and the at least one projection 31 are formed such that axial forces can be introduced from the securing cap 11 into the closure cap 9. This makes it possible that the cap 9 is taken when the safety cap 11 is separated and removed from the locking ring 15. To expose the needle hub 7 for use of the syringe 1, it is then not necessary to first remove the safety cap 11 and then the cap 9, but both elements are removed at the same time when the cap 11 is removed.
  • the at least one projection 31 and the at least one recess 29 are formed such that forces acting in the circumferential direction can also be introduced from the securing cap 11 into the closure cap 9 or vice versa. As a result, a relative rotation between the safety cap 11 and the cap 9 is effectively prevented. This increases the tightness of the closure 3, because the closure cap 9 does not move in the safety cap 11, in particular can not be rotated.
  • Preference is here - seen in the circumferential direction - a plurality of recesses 29 and projections 31, particularly preferably at the same angular distance from each other, is provided.
  • the safety cap 11 and the closure cap 9 are formed as an integral element, and in particular the fact that the two elements are locked together, the overall height or extension - seen in the longitudinal or axial direction - of the closure 3 can be reduced. Namely, if these elements are formed in two pieces, the securing cap 11 not only has to cover over the cap 9 but also to protect it against loss or unauthorized removal or - in the axial direction - to stabilize it. If the elements, however, formed integrally with each other, in particular locked together, it is sufficient if the safety cap 11, the closure cap 9 - as seen in the circumferential direction - surrounds, as shown in Figure 1 and in Figure 2.
  • cap 9 is accessible from above in the illustration of Figure 2, it can not be removed from the needle hub 7 as long as the safety cap 11 is connected to the retaining ring 15.
  • the closure 3 can therefore - seen in the longitudinal direction - have a shorter extension or smaller overall height.

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Mechanical Engineering (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Closures For Containers (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)

Abstract

L'invention concerne une seringue constituée d'un cylindre de seringue (5) et d'une embase d'aiguille (7) située à une extrémité distale (D) du cylindre de seringue (5), la seringue (1) étant munie d'un bouchon (3) comprenant un capuchon obturateur (9), obturant de manière étanche l'embase d'aiguille (7), et un capuchon de sécurité (11), le capuchon de sécurité (11) enveloppant le capuchon obturateur (9) et étant fixé à l'embase d'aiguille (7) par l'intermédiaire d'une bague de maintien (13). La seringue est caractérisée en ce qu'au moins le capuchon de sécurité (11) et le capuchon obturateur (9) sont réalisés d'un seul tenant.
EP12706468.1A 2011-03-03 2012-02-23 Bouchon pour seringue et procédé de fabrication Withdrawn EP2680908A1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE201110013791 DE102011013791A1 (de) 2011-03-03 2011-03-03 Verschluss und Verfahren zur Herstellung eines Verschlusses
DE102011107276 2011-07-15
DE201110111552 DE102011111552A1 (de) 2011-03-03 2011-08-24 Spritze, Verschluss für eine Spritze und Verfahren zum Herstellen eines Verschlusses
PCT/EP2012/000785 WO2012116790A1 (fr) 2011-03-03 2012-02-23 Bouchon pour seringue et procédé de fabrication

Publications (1)

Publication Number Publication Date
EP2680908A1 true EP2680908A1 (fr) 2014-01-08

Family

ID=46757371

Family Applications (2)

Application Number Title Priority Date Filing Date
EP12709011.6A Withdrawn EP2680909A1 (fr) 2011-03-03 2012-02-23 Bouchon et procédé de fabrication dudit bouchon
EP12706468.1A Withdrawn EP2680908A1 (fr) 2011-03-03 2012-02-23 Bouchon pour seringue et procédé de fabrication

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EP12709011.6A Withdrawn EP2680909A1 (fr) 2011-03-03 2012-02-23 Bouchon et procédé de fabrication dudit bouchon

Country Status (8)

Country Link
US (2) US20130338603A1 (fr)
EP (2) EP2680909A1 (fr)
JP (2) JP2014508602A (fr)
BR (2) BR112013022563A2 (fr)
CA (2) CA2828919A1 (fr)
MX (2) MX2013010047A (fr)
RU (2) RU2013144355A (fr)
WO (2) WO2012116791A1 (fr)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012049532A1 (fr) 2010-12-16 2012-04-19 Becton Dickinson France Adaptateur et dispositif d'administration de médicament
RU2013144355A (ru) * 2011-03-03 2015-04-10 Феттер Фарма-Фертигунг Гмбх Унд Ко. Кг Крышка для шприца и способ ее изготовления
NZ706006A (en) * 2012-09-26 2017-03-31 Bayer Pharma AG Prefilled syringe
DE102012022359A1 (de) * 2012-11-15 2014-05-15 Vetter Pharma-Fertigung GmbH & Co. KG Aufsatz für eine Spritze oder Karpule
DE102013200339A1 (de) 2013-01-11 2014-07-17 Vetter Pharma-Fertigung GmbH & Co. KG Befestigungselement und Spritze
DE102013204134A1 (de) * 2013-03-11 2014-09-11 Vetter Pharma-Fertigung GmbH & Co. KG Aufsatz für eine Spritze, Karpule oder dergleichen
US10022301B2 (en) * 2013-03-15 2018-07-17 Becton Dickinson and Company Ltd. Connection system for medical device components
EP2826519A1 (fr) * 2013-07-15 2015-01-21 Becton Dickinson France Adaptateur pour un dispositif d'administration de médicament et procédé pour monter ledit adaptateur sur celui-ci
EP2862587A1 (fr) 2013-10-15 2015-04-22 Becton Dickinson France Ensemble bouchon d'extrémité pour fermer un système d'injection
JP1528650S (fr) 2014-06-20 2015-07-13
DE102014114403A1 (de) 2014-10-02 2016-04-07 Gerresheimer Regensburg Gmbh Stopfen zum Aufsetzen auf ein Anschlusselement einer medizinischen Spritze
FR3038228B1 (fr) * 2015-06-30 2017-07-28 Crossject Dispositif d’injection sans aiguille a bouchon de fermeture positionnable angulairement
CN108601910A (zh) 2015-11-27 2018-09-28 赛诺菲-安万特德国有限公司 注射装置的部件、系统和方法
EP3189867B1 (fr) * 2016-01-06 2022-11-16 Ypsomed AG Procédé de fabrication de pièces et assemblage de pièces pour un dispositif d'injection par moulage par injection à deux composants
EP3269418A1 (fr) * 2016-07-12 2018-01-17 Becton Dickinson France Ensemble de capuchon d'extrémité, système médical d'injection et procédé de production d'un système médical d'injection
DE102017200007A1 (de) 2017-01-02 2018-07-05 Schott Ag Spritze mit unterschiedlichen Materialien
FR3063909B1 (fr) * 2017-03-17 2022-03-11 Biocorp Prod Dispositif de protection d'aiguille pour une seringue pre-remplie a aiguille collee et seringue comprenant un tel dispositif
ES2755758T3 (es) 2017-03-31 2020-04-23 Schott Kaisha Private Ltd Conjunto de tapa de punta de jeringa, jeringa que comprende dicha tapa de punta de jeringa y método para obturar un cilindro de jeringa
USD862694S1 (en) 2017-11-08 2019-10-08 Schott Kaisha Pvt. Ltd Syringe cap for sealing syringe for medical purpose
WO2019123488A1 (fr) * 2017-12-19 2019-06-27 Matex Lab S.P.A. Cartouche pour seringue et seringue correspondante
EP3569272A1 (fr) * 2018-05-14 2019-11-20 SCHOTT Schweiz AG Fermeture pour un récipient pour préparations pharmaceutiques et récipient pourvu d'une telle fermeture
FR3084263B1 (fr) * 2018-07-27 2020-07-10 Laboratoire Aguettant Systeme d’administration comportant un dispositif d’administration et un dispositif de protection pourvu d’une membrane de fermeture
US10661030B1 (en) 2018-11-28 2020-05-26 Fresenius Kabi Usa, Llc Tamper evident cap for syringes
EP3821925B1 (fr) 2019-09-18 2024-03-20 KAISHA PACKAGING Private Ltd. Dispositif permettant de verrouiller une tige de piston d'une seringue après utilisation et de prévenir la réutilisation de la seringue et ensemble seringue
USD953368S1 (en) * 2020-07-30 2022-05-31 Sanofi Display panel portion with an animated computer icon
USD953367S1 (en) * 2020-07-30 2022-05-31 Sanofi Display panel portion with an animated computer icon
USD949195S1 (en) * 2020-07-30 2022-04-19 Sanofi Display panel portion with an animated computer icon
USD952674S1 (en) * 2020-07-30 2022-05-24 Sanofi Display panel portion with an animated computer icon
USD947889S1 (en) * 2020-07-30 2022-04-05 Sanofi Display panel portion with an animated computer icon
USD953366S1 (en) * 2020-07-30 2022-05-31 Sanofi Display panel portion with an animated computer icon
USD958834S1 (en) * 2020-07-30 2022-07-26 Sanofi Display panel portion with an animated computer icon
USD952675S1 (en) * 2020-07-30 2022-05-24 Sanofi Display panel portion with an animated computer icon
USD958183S1 (en) * 2020-07-30 2022-07-19 Sanofi Display panel portion with an animated computer icon
US12005238B2 (en) 2020-10-20 2024-06-11 Fresenius Kabi Usa, Llc Impact resistant and tamper evident system for prefilled syringe
USD1003307S1 (en) * 2020-10-30 2023-10-31 Embecta Corp. Display screen or portion thereof with a graphical user interface for an integrated disease management system
USD966304S1 (en) * 2021-02-25 2022-10-11 Rightpoint Consulting, LLC Display panel portion with an animated computer icon
USD969843S1 (en) * 2021-02-25 2022-11-15 Rightpoint Consulting, LLC Display panel portion with an animated computer icon
USD966301S1 (en) * 2021-02-25 2022-10-11 Rightpoint Consulting, LLC Display panel portion with an animated computer icon
USD965624S1 (en) * 2021-02-25 2022-10-04 Rightpoint Consulting, LLC Display panel portion with an animated computer icon
USD1039567S1 (en) * 2021-09-06 2024-08-20 Roche Diabetes Care, Inc. Display screen or portion thereof with a graphical user interface

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE108675T1 (de) * 1989-05-17 1994-08-15 Vetter & Co Apotheker Spritze für medizinische zwecke.
US6196998B1 (en) * 1994-12-12 2001-03-06 Becton Dickinson And Company Syringe and tip cap assembly
US5624402A (en) * 1994-12-12 1997-04-29 Becton, Dickinson And Company Syringe tip cap
US5807345A (en) * 1995-06-30 1998-09-15 Abbott Laboratories Luer cap for terminally sterilized syringe
JP3828951B2 (ja) * 1995-12-22 2006-10-04 リケンテクノス株式会社 医療用栓
DE19652708C2 (de) * 1996-12-18 1999-08-12 Schott Glas Verfahren zum Herstellen eines befüllten Kunststoff-Spritzenkorpus für medizinische Zwecke
CN100471535C (zh) * 1998-05-29 2009-03-25 劳伦斯A·林恩 路厄氏接纳器与输液的方法
DE19909824A1 (de) * 1999-03-05 2000-09-07 Vetter & Co Apotheker Spritze für medizinische Zwecke und Verfahren zu ihrer Montage
DE19950039C1 (de) * 1999-10-16 2001-04-26 Bayerische Motoren Werke Ag Herstellverfahren für ein aus zumindest zwei Komponenten bestehendes Kunststoff-Spritzguß-Bauteil
DE19954373B4 (de) * 1999-11-11 2011-01-27 Helvoet Pharma Belgium N.V. Schutzkappe für eine Kanüle
JP3591636B2 (ja) * 2000-04-03 2004-11-24 ニプロ株式会社 プレフィルドシリンジ
US6193688B1 (en) * 2000-07-17 2001-02-27 Bracco Diagnostics, Inc. Tamper evident protector cap for pre-filled syringe barrels
DE10247965A1 (de) * 2002-10-15 2004-05-06 Transcoject Gesellschaft für medizinische Geräte mbH & Co KG Originalitätsverschluss für eine Spritze
DE102005054075A1 (de) * 2005-11-12 2007-05-16 Vetter & Co Apotheker Kanülenaufsatz für eine Spritze oder Karpule
RU2013144355A (ru) * 2011-03-03 2015-04-10 Феттер Фарма-Фертигунг Гмбх Унд Ко. Кг Крышка для шприца и способ ее изготовления

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO2012116790A1 *

Also Published As

Publication number Publication date
US20130338604A1 (en) 2013-12-19
BR112013022565A2 (pt) 2016-12-06
EP2680909A1 (fr) 2014-01-08
MX2013009991A (es) 2014-03-27
RU2013144355A (ru) 2015-04-10
RU2013144348A (ru) 2015-04-10
CA2828904A1 (fr) 2012-09-07
BR112013022563A2 (pt) 2016-12-06
MX2013010047A (es) 2014-01-31
JP2014508602A (ja) 2014-04-10
WO2012116791A1 (fr) 2012-09-07
CA2828919A1 (fr) 2012-09-07
JP2014508601A (ja) 2014-04-10
US20130338603A1 (en) 2013-12-19
WO2012116790A1 (fr) 2012-09-07

Similar Documents

Publication Publication Date Title
EP2680908A1 (fr) Bouchon pour seringue et procédé de fabrication
EP1600190B1 (fr) Capuchon de seringue et méthode de fabrication d'un capuchon de seringue
EP2900301B1 (fr) Seringue préremplie
EP1410819B1 (fr) Fermeture anti-réutilisation pour une seringue
DE102006040888B3 (de) Verschlusssystem für Behältnisse
DE102008009418B3 (de) Verschlusskappe
EP2916894B1 (fr) Obturateur de seringue
EP1951343B1 (fr) Chapeau pour une seringue ou pour une carpule
WO2009109312A1 (fr) Fermeture inviolable avec une goupille de retenue
DE2909002B2 (de) Injektionsspritze für einmalige Verwendung
EP2788058A2 (fr) Obturateur, notamment obturateur de seringue pour l'obturation étanche d'une ouverture distale d'un corps de seringue
DE102011111552A1 (de) Spritze, Verschluss für eine Spritze und Verfahren zum Herstellen eines Verschlusses
DE102011013791A1 (de) Verschluss und Verfahren zur Herstellung eines Verschlusses
EP1410817A1 (fr) Cylindre de seringue
DE102016219889B4 (de) Dichtring
EP2607252B1 (fr) Agencement d'un récipient en verre tubulaire et d'une fermeture en une pièce pour le récipient
DE102016118767A1 (de) Verfahren zum Herstellen einer Spritze mit einem integrierten Verschlusselement
EP1154812B1 (fr) Dispositif d'injection
DE202016101947U1 (de) Verbindungsvorrichtung zur Verbindung einer medizinischen Schlauchleitung mit einer Flasche
EP3807163B1 (fr) Procédé pour la fabrication d'une fermeture de sécurité, pièce moulée par injection ainsi que fermeture de sécurité
AT523947B1 (de) Vorrichtung zur Zudosierung eines Dosiermittels für eine in einer Flasche abgefüllte Flüssigkeit
EP4445928A1 (fr) Seringue
AT525541A4 (de) Aufnahmeeinrichtung mit Septum und Verfahren zu dessen Herstellung
WO2023067079A1 (fr) Composant de fermeture pour un corps médical creux, corps médical creux doté d'un tel composant de fermeture, et procédé de production d'un tel composant de fermeture
EP4419174A1 (fr) Composant de fermeture pour un corps médical creux, corps médical creux doté d'un tel composant de fermeture, et procédé de production d'un tel composant de fermeture

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20131004

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAX Request for extension of the european patent (deleted)
17Q First examination report despatched

Effective date: 20141107

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20150519